Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion type Assertion NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_head.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion description "[Together, our data suggest that proteasome- or XIAP-targeting drugs offer a novel therapeutic approach to overcome TRAIL resistance in PIK3CA-mutated CRC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_provenance.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion evidence source_evidence_literature NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_provenance.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion SIO_000772 25501831 NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_provenance.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion wasDerivedFrom befree-2016 NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_provenance.
- NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_assertion wasGeneratedBy ECO_0000203 NP1247648.RASZhgGyqa_ongyCbIzNS8nxEEeicTLpoy5NN6GqJ0DA0130_provenance.